Ocular Adverse Events of Pembrolizumab: Disproportionality Analysis and Case-Based Clinical Insights

SSRN Electronic Journal 2026 Preprint Open access

Read full text
Authors: Shabeer Ali Thorakkattil, Mahmathi Karuppannan, Hanis Hanum Zulkifly, Fazlin Mohd Fauzi, Suhaj Abdulsalim, Savera Ikram Arain, Mohammed Salim Karattuthodi
DOI: 10.2139/ssrn.5996283
Cited by: 0

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Ocular Oncology and Treatments Retinal Diseases and Treatments

Publication details

Journal / source
SSRN Electronic Journal
Publication date
1 January 2026
Document type
Preprint